Topic

Texas

A collection of 402 issues

How to Get Uplizna (Inebilizumab) Covered by Cigna in Texas: Complete Guide to Prior Authorization, Appeals, and Approval Strategies

Answer Box: Getting Uplizna (Inebilizumab) Covered by Cigna in Texas Uplizna (inebilizumab) requires prior authorization from Cigna and is typically covered for AQP4-positive NMOSD when prescribed by a neurologist with documented step therapy. Your fastest path: (1) Have your neurologist submit a prior authorization through CoverMyMeds or Cigna's
6 min read

How to Get Krystexxa (Pegloticase) Covered by UnitedHealthcare in Texas: Complete Timeline and Appeals Guide

Answer Box: Getting Krystexxa Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Krystexxa (pegloticase) with strict step therapy and documentation requirements. The standard approval timeline is 15 days for complete submissions, with expedited reviews decided within 24 hours for urgent cases. To start: gather evidence of failed allopurinol
5 min read

How to Get iLink® Corneal Cross-Linking Covered by Cigna in Texas: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting iLink® Covered by Cigna in Texas Cigna covers iLink® corneal cross-linking for progressive keratoconus when you meet specific criteria: age 14-65, documented disease progression, and use of the FDA-approved epithelium-off protocol only. Your fastest path: Have your ophthalmologist submit prior authorization with serial topography showing progression (≥1
7 min read

How to Get Cabometyx (cabozantinib) Covered by Blue Cross Blue Shield of Texas: Forms, Appeals, and Specialty Pharmacy Guide

Answer Box: Getting Cabometyx Covered by BCBS Texas Cabometyx (cabozantinib) requires prior authorization from Blue Cross Blue Shield of Texas for all 2024 commercial plans. Submit your request through CoverMyMeds or the BCBS Texas provider portal with complete clinical documentation including diagnosis, prior treatments, and medical necessity justification. If denied,
6 min read